Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Northwestern Medicine Delnor Hospital located at 300 Randall Rd, Geneva, IL, 60134 & includes data from NPIs 1407859655
Dexur analyzed Q3 2019 (July to September 2019) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Northwestern Medicine Delnor Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 839 | 814 | ||||||||||
| Surgical | 168 | 163 | ||||||||||
| Non Surgical | 671 | 651 | ||||||||||
| General Medicine | 153 | 143 | ||||||||||
| Cardiovascular | 138 | 131 | ||||||||||
| Orthopedics | 95 | 93 | ||||||||||
| Gastroenterology & Endocrinology | 94 | 93 | ||||||||||
| Pulmonology | 94 | 92 | ||||||||||
| Urology | 77 | 77 | ||||||||||
| Neurology | 71 | 71 | ||||||||||
| Oncology & Hematology | 40 | 39 | ||||||||||
| General Surgery | 38 | 36 | ||||||||||
| Psychiatry & Mental Disorders | 11 | 11 |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Bronchitis And Asthma | ||||||||||||
| Pulmonary Embolism |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| Degenerative Nervous System Disorders |
| Total Hospitalizations (Jul 2019 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Illinois Total Hospitalizations (Jul 2019 to Sep 2019) | Illinois Total Hospitalizations After Exclusion | Illinois Total Users | Illinois SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2019 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders |